Document is current

Article History

Received: 11 December 2024

Accepted: 27 May 2025

First Online: 13 June 2025

Declarations

:

: FTN has nothing to declare in the context of this paper but several ad hoc consultancies/speaking honoraria and/or research funding from AMGEN, Asofarma, FAES Farma, and Menarini. HGH has nothing to declare in the context of this paper but several ad hoc speaking honoraria from AMGEN, Asofarma, and MSD. PAG, RLC, HAA, RBT, ABA, JMC, RMD, EPF, ARE, and AVA have no conflicts of interest.

: Although most clinical recommendations are intended to be applied nationwide, social disparities may prevent full implementation in certain regions. However, these recommendations can serve as a valuable reference for public health agencies and policymakers, guiding the improved allocation of health resources based on a solid national medical position. Furthermore, feedback from clinicians and healthcare administrators may lead to future revisions and updates as necessary.

: The following societies endorse this consensus report: College of Internal Medicine of Mexico (CMIM), Mexican Academy of Geriatrics (AMG), Mexican Association for the Study of Climacteric (AMEC), Mexican Association of Bone and Mineral Metabolism (AMMOM), Mexican College of Orthopedics and Traumatology (CMO), Mexican College of Rheumatology (CMR), National College of Geriatric Medicine (CONAMEGER), Mexican Federation of Obstetrics and Gynecology Colleges (FEMECOG), Mexican Federation of Orthopedics and Traumatology Colleges (FEMECOT).